Cargando…
Recurrence of a t(8;21)-Positive Acute Myeloid Leukemia in the Form of a Granulocytic Sarcoma Involving Cranial Bones: A Diagnostic and Therapeutic Challenge
Granulocytic sarcoma (GS) is a rare extramedullary solid tumor defined as an accumulation of myeloblasts or immature myeloid cells. It can cooccur with or precede the acute myeloid leukemia (AML) as well as following treated AML. The incidence of GS in AML patients is 3–8% but it significantly rises...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787645/ https://www.ncbi.nlm.nih.gov/pubmed/24109526 http://dx.doi.org/10.1155/2013/245395 |
_version_ | 1782286212238671872 |
---|---|
author | Di Veroli, Ambra Micarelli, Alessandro Cefalo, Mariagiovanna Ceresoli, Eleonora Nasso, Daniela Cicconi, Laura Mauramati, Simone Ottaviani, Fabrizio Venditti, Adriano Amadori, Sergio |
author_facet | Di Veroli, Ambra Micarelli, Alessandro Cefalo, Mariagiovanna Ceresoli, Eleonora Nasso, Daniela Cicconi, Laura Mauramati, Simone Ottaviani, Fabrizio Venditti, Adriano Amadori, Sergio |
author_sort | Di Veroli, Ambra |
collection | PubMed |
description | Granulocytic sarcoma (GS) is a rare extramedullary solid tumor defined as an accumulation of myeloblasts or immature myeloid cells. It can cooccur with or precede the acute myeloid leukemia (AML) as well as following treated AML. The incidence of GS in AML patients is 3–8% but it significantly rises in M2 FAB subtype AML. This variety of AML harbors t(8;21) in up to 20–25% of cases (especially in children and black ones of African origin) and, at a molecular level, it is characterized by the generation of a fusion gene known as RUNX1-RUNX1T1. Approximately 10% of M2 AML patients will develop GS, as a consequence, the t(8;21) and the relative transcript represent the most common cytogenetic and molecular abnormalities in GS. FLT3-ITD mutation was rarely described in AML patients presenting with GS. FLT3 ITD is generally strongly associated with poor prognosis in AML, and is rarely reported in patients with t(8;21). GS presentation is extremely variable depending on organs involved; in general, cranial bones and sinus are very rarely affected sites. We report a rare case of GS occurring as a recurrence of a previously treated t(8;21), FLT3-ITD positive AML, involving mastoid bones and paravertebral tissues. |
format | Online Article Text |
id | pubmed-3787645 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-37876452013-10-09 Recurrence of a t(8;21)-Positive Acute Myeloid Leukemia in the Form of a Granulocytic Sarcoma Involving Cranial Bones: A Diagnostic and Therapeutic Challenge Di Veroli, Ambra Micarelli, Alessandro Cefalo, Mariagiovanna Ceresoli, Eleonora Nasso, Daniela Cicconi, Laura Mauramati, Simone Ottaviani, Fabrizio Venditti, Adriano Amadori, Sergio Case Rep Hematol Case Report Granulocytic sarcoma (GS) is a rare extramedullary solid tumor defined as an accumulation of myeloblasts or immature myeloid cells. It can cooccur with or precede the acute myeloid leukemia (AML) as well as following treated AML. The incidence of GS in AML patients is 3–8% but it significantly rises in M2 FAB subtype AML. This variety of AML harbors t(8;21) in up to 20–25% of cases (especially in children and black ones of African origin) and, at a molecular level, it is characterized by the generation of a fusion gene known as RUNX1-RUNX1T1. Approximately 10% of M2 AML patients will develop GS, as a consequence, the t(8;21) and the relative transcript represent the most common cytogenetic and molecular abnormalities in GS. FLT3-ITD mutation was rarely described in AML patients presenting with GS. FLT3 ITD is generally strongly associated with poor prognosis in AML, and is rarely reported in patients with t(8;21). GS presentation is extremely variable depending on organs involved; in general, cranial bones and sinus are very rarely affected sites. We report a rare case of GS occurring as a recurrence of a previously treated t(8;21), FLT3-ITD positive AML, involving mastoid bones and paravertebral tissues. Hindawi Publishing Corporation 2013 2013-09-12 /pmc/articles/PMC3787645/ /pubmed/24109526 http://dx.doi.org/10.1155/2013/245395 Text en Copyright © 2013 Ambra Di Veroli et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Di Veroli, Ambra Micarelli, Alessandro Cefalo, Mariagiovanna Ceresoli, Eleonora Nasso, Daniela Cicconi, Laura Mauramati, Simone Ottaviani, Fabrizio Venditti, Adriano Amadori, Sergio Recurrence of a t(8;21)-Positive Acute Myeloid Leukemia in the Form of a Granulocytic Sarcoma Involving Cranial Bones: A Diagnostic and Therapeutic Challenge |
title | Recurrence of a t(8;21)-Positive Acute Myeloid Leukemia in the Form of a Granulocytic Sarcoma Involving Cranial Bones: A Diagnostic and Therapeutic Challenge |
title_full | Recurrence of a t(8;21)-Positive Acute Myeloid Leukemia in the Form of a Granulocytic Sarcoma Involving Cranial Bones: A Diagnostic and Therapeutic Challenge |
title_fullStr | Recurrence of a t(8;21)-Positive Acute Myeloid Leukemia in the Form of a Granulocytic Sarcoma Involving Cranial Bones: A Diagnostic and Therapeutic Challenge |
title_full_unstemmed | Recurrence of a t(8;21)-Positive Acute Myeloid Leukemia in the Form of a Granulocytic Sarcoma Involving Cranial Bones: A Diagnostic and Therapeutic Challenge |
title_short | Recurrence of a t(8;21)-Positive Acute Myeloid Leukemia in the Form of a Granulocytic Sarcoma Involving Cranial Bones: A Diagnostic and Therapeutic Challenge |
title_sort | recurrence of a t(8;21)-positive acute myeloid leukemia in the form of a granulocytic sarcoma involving cranial bones: a diagnostic and therapeutic challenge |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787645/ https://www.ncbi.nlm.nih.gov/pubmed/24109526 http://dx.doi.org/10.1155/2013/245395 |
work_keys_str_mv | AT diveroliambra recurrenceofat821positiveacutemyeloidleukemiaintheformofagranulocyticsarcomainvolvingcranialbonesadiagnosticandtherapeuticchallenge AT micarellialessandro recurrenceofat821positiveacutemyeloidleukemiaintheformofagranulocyticsarcomainvolvingcranialbonesadiagnosticandtherapeuticchallenge AT cefalomariagiovanna recurrenceofat821positiveacutemyeloidleukemiaintheformofagranulocyticsarcomainvolvingcranialbonesadiagnosticandtherapeuticchallenge AT ceresolieleonora recurrenceofat821positiveacutemyeloidleukemiaintheformofagranulocyticsarcomainvolvingcranialbonesadiagnosticandtherapeuticchallenge AT nassodaniela recurrenceofat821positiveacutemyeloidleukemiaintheformofagranulocyticsarcomainvolvingcranialbonesadiagnosticandtherapeuticchallenge AT cicconilaura recurrenceofat821positiveacutemyeloidleukemiaintheformofagranulocyticsarcomainvolvingcranialbonesadiagnosticandtherapeuticchallenge AT mauramatisimone recurrenceofat821positiveacutemyeloidleukemiaintheformofagranulocyticsarcomainvolvingcranialbonesadiagnosticandtherapeuticchallenge AT ottavianifabrizio recurrenceofat821positiveacutemyeloidleukemiaintheformofagranulocyticsarcomainvolvingcranialbonesadiagnosticandtherapeuticchallenge AT vendittiadriano recurrenceofat821positiveacutemyeloidleukemiaintheformofagranulocyticsarcomainvolvingcranialbonesadiagnosticandtherapeuticchallenge AT amadorisergio recurrenceofat821positiveacutemyeloidleukemiaintheformofagranulocyticsarcomainvolvingcranialbonesadiagnosticandtherapeuticchallenge |